D Wave Quantum Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? D Wave Quantum Inc trades at $14.85 (market cap $5.78B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: D Wave Quantum Inc is far larger — about 2.5× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals.
| QBTS | SLS | |
|---|---|---|
Market Cap | $5.78B | $2.28B |
Volume | 14,335,003 | 3,128,960 |
Sector | Technology | Health |
52-Week High | $44.78 | $15.46 |
52-Week Low | $12.98 | $1.39 |
Typical Hold Time | 32 Days | — |
Enterprise Value | $5.28B | $2.15B |
Signals from Pluang's Aura AI — not financial advice
QBTS (D-Wave Quantum Inc.) trades at $15.22, down 3.61% on the day, amid a bearish technical signal despite a 100% analyst buy rating with a consensus price target of $34.38. The company shows significant financial strain with a net income margin of -2,001.59% and negative cash flow from operations, though it maintains a high gross margin of 64.19%. Recent news highlights ongoing fraud investigations alongside technological advancements in quantum computing.
The stock presents high risk due to severe losses and cash burn, but offers speculative upside if the company can monetize its quantum technology. Investors face substantial volatility from operational challenges and legal scrutiny, requiring caution despite Wall Street optimism.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →